SHANDONG XINHUA (00719) announced that the company has recently received the Drug Registration Certificate for Minoxidil topical solution (the "Product") approved and issued by the National Medical Products Administration, granting approval for the Product's registration. SHANDONG XINHUA's Minoxidil topical solution received approval in August 2025, which will help diversify the company's product portfolio and enhance its overall competitive strength.